It is differentiated from FAP based on the clinical criteria (presence of more than five juvenile polyps in the colon or multiple juvenile polyps throughout the GI tract) and genetic testing for BMPR1A and SMAD4 mutations, which are absent in FAP. Here, SMAD4 is linked to Familial adenomatous polyposis.